Skip to content

Clinical trials

Lung Neoplasms trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Philippines Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20093
20151
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Amgen1
Arcus Biosciences, Inc.1
Genentech, Inc.1
Genzyme, a Sanofi Company1
Gustave Roussy, Cancer Campus, Grand Paris1
Hanmi Pharmaceutical Company Limited1
Lung Center of the Philippines1
Merck Sharp & Dohme LLC1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms11
Carcinoma, Non-Small-Cell Lung10
Neoplasms2
Adenocarcinoma of Lung1
Anemia1
COVID-191
Carcinoma1
Hemoptysis1
Lung Diseases1
Neoplasms by Histologic Type1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.